Federal award
MAPP BIOPHARMACEUTICAL, INC.
W911QY20C0099
ContractSBIR/STTR ST2
Obligated and Ceiling
- Obligated (net)
- $1,499,004.12
- Ceiling (potential value, not spending)
- $1,499,004.12
- Current value
- $1,499,004.12
- Gross positive obligations
- $1,499,004.12
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AD25 · R&D- DEFENSE OTHER: SERVICES (OPERATIONAL SYSTEMS DEVELOPMENT)
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- W911QY20C0099
- Award type code
- D
- Actions
- 6 · Aug 5, 2020 to Jun 22, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 22, 2023 | FY2023 | P00004 | M | $0.00 | — |
| Mar 17, 2022 | FY2022 | P00003 | D | $0.00 | — |
| Jan 20, 2022 | FY2022 | P00002 | D | $499,970.00 | — |
| Apr 28, 2021 | FY2021 | P00001 | C | $499,517.06 | — |
| Apr 20, 2021 | FY2021 | ARZ999 | M | $0.00 | — |
| Aug 5, 2020 | FY2020 | 0 | — | $499,517.06 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.